Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 125 entries
Sorted by: Best Match Show Resources per page
Psychopathology of time in brain disease and schizophrenia.

Behavioural neurology

Cutting J, Silzer H.
PMID: 24487296
Behav Neurol. 1990;3(4):197-215. doi: 10.3233/BEN-1990-3401.

The literature on disturbance of time-sense in brain disease and schizophrenia is reviewed and the subjective experience of altered time-sense reported by 45 out of 350 personally interviewed schizophrenics is analyzed. A review of the literature on the effect...

Cite
Cutting J, Silzer H. Psychopathology of time in brain disease and schizophrenia. Behav Neurol. 1990;3(4):197-215doi: 10.3233/BEN-1990-3401.
Cutting, J., & Silzer, H. (1990). Psychopathology of time in brain disease and schizophrenia. Behavioural neurology, 3(4), 197-215. https://doi.org/10.3233/BEN-1990-3401
Cutting, J, and Silzer, H. "Psychopathology of time in brain disease and schizophrenia." Behavioural neurology vol. 3,4 (1990): 197-215. doi: https://doi.org/10.3233/BEN-1990-3401
Cutting J, Silzer H. Psychopathology of time in brain disease and schizophrenia. Behav Neurol. 1990;3(4):197-215. doi: 10.3233/BEN-1990-3401. PMID: 24487296.
Copy Download .nbib Format: NLM
The lateral port control pharyngeal flap: a thirty-year evolution and followup.

Plastic surgery international

Boutros S, Cutting C.
PMID: 23365734
Plast Surg Int. 2013;2013:237308. doi: 10.1155/2013/237308. Epub 2013 Jan 13.

In 1971, Micheal Hogan introduced the Lateral Port Control Pharyngeal Flap (LPCPF) which obtained good results with elimination of VPI. However, there was a high incidence of hyponasality and OSA. We hypothesized that preoperative assessment with videofluoroscopy and nasal...

Cite
Boutros S, Cutting C. The lateral port control pharyngeal flap: a thirty-year evolution and followup. Plast Surg Int. 2013;2013:237308doi: 10.1155/2013/237308.
Boutros, S., & Cutting, C. (2013). The lateral port control pharyngeal flap: a thirty-year evolution and followup. Plastic surgery international, 2013237308. https://doi.org/10.1155/2013/237308
Boutros, Sean, and Cutting, Court. "The lateral port control pharyngeal flap: a thirty-year evolution and followup." Plastic surgery international vol. 2013 (2013): 237308. doi: https://doi.org/10.1155/2013/237308
Boutros S, Cutting C. The lateral port control pharyngeal flap: a thirty-year evolution and followup. Plast Surg Int. 2013;2013:237308. doi: 10.1155/2013/237308. Epub 2013 Jan 13. PMID: 23365734; PMCID: PMC3556884.
Copy Download .nbib Format: NLM
Improving imputation in disease-relevant regions: lessons from cystic fibrosis.

NPJ genomic medicine

Panjwani N, Xiao B, Xu L, Gong J, Keenan K, Lin F, He G, Baskurt Z, Kim S, Zhang L, Esmaeili M, Blackman S, Scherer SW, Corvol H, Drumm M, Knowles M, Cutting G, Rommens JM, Sun L, Strug LJ.
PMID: 29581887
NPJ Genom Med. 2018 Mar 20;3:8. doi: 10.1038/s41525-018-0047-6. eCollection 2018.

Does genotype imputation with public reference panels identify variants contributing to disease? Genotype imputation using the 1000 Genomes Project (1KG; 2504 individuals) displayed poor coverage at the causal cystic fibrosis (CF) transmembrane conductance regulator (

Cite
Panjwani N, Xiao B, Xu L, et al. Improving imputation in disease-relevant regions: lessons from cystic fibrosis. NPJ Genom Med. 2018;3:8doi: 10.1038/s41525-018-0047-6.
Panjwani, N., Xiao, B., Xu, L., Gong, J., Keenan, K., Lin, F., He, G., Baskurt, Z., Kim, S., Zhang, L., Esmaeili, M., Blackman, S., Scherer, S. W., Corvol, H., Drumm, M., Knowles, M., Cutting, G., Rommens, J. M., Sun, L., & Strug, L. J. (2018). Improving imputation in disease-relevant regions: lessons from cystic fibrosis. NPJ genomic medicine, 38. https://doi.org/10.1038/s41525-018-0047-6
Panjwani, Naim, et al. "Improving imputation in disease-relevant regions: lessons from cystic fibrosis." NPJ genomic medicine vol. 3 (2018): 8. doi: https://doi.org/10.1038/s41525-018-0047-6
Panjwani N, Xiao B, Xu L, Gong J, Keenan K, Lin F, He G, Baskurt Z, Kim S, Zhang L, Esmaeili M, Blackman S, Scherer SW, Corvol H, Drumm M, Knowles M, Cutting G, Rommens JM, Sun L, Strug LJ. Improving imputation in disease-relevant regions: lessons from cystic fibrosis. NPJ Genom Med. 2018 Mar 20;3:8. doi: 10.1038/s41525-018-0047-6. eCollection 2018. PMID: 29581887; PMCID: PMC5861096.
Copy Download .nbib Format: NLM
A response to editorial 'a holistic approach to examining the evidence', JWC 2017; 26(11):609.

Journal of wound care

Cutting K, White R, Legerstee R.
PMID: 29244963
J Wound Care. 2017 Dec 02;26(12):788-789. doi: 10.12968/jowc.2017.26.12.788a.

No abstract available.

Cite
Cutting K, White R, Legerstee R. A response to editorial 'a holistic approach to examining the evidence', JWC 2017; 26(11):609. J Wound Care. 2017;26(12):788-789doi: 10.12968/jowc.2017.26.12.788a.
Cutting, K., White, R., & Legerstee, R. (2017). A response to editorial 'a holistic approach to examining the evidence', JWC 2017; 26(11):609. Journal of wound care, 26(12), 788-789. https://doi.org/10.12968/jowc.2017.26.12.788a
Cutting, K, et al. "A response to editorial 'a holistic approach to examining the evidence', JWC 2017; 26(11):609." Journal of wound care vol. 26,12 (2017): 788-789. doi: https://doi.org/10.12968/jowc.2017.26.12.788a
Cutting K, White R, Legerstee R. A response to editorial 'a holistic approach to examining the evidence', JWC 2017; 26(11):609. J Wound Care. 2017 Dec 02;26(12):788-789. doi: 10.12968/jowc.2017.26.12.788a. PMID: 29244963.
Copy Download .nbib Format: NLM
Linking beaver dam affected flow dynamics to upstream passage of Arctic grayling.

Ecology and evolution

Cutting KA, Ferguson JM, Anderson ML, Cook K, Davis SC, Levine R.
PMID: 30619592
Ecol Evol. 2018 Dec 04;8(24):12905-12917. doi: 10.1002/ece3.4728. eCollection 2018 Dec.

Beaver reintroductions and beaver dam structures are an increasingly utilized ecological tool for rehabilitating degraded streams, yet beaver dams can potentially impact upstream fish migrations. We collected two years of data on Arctic grayling movement through a series of...

Cite
Cutting KA, Ferguson JM, Anderson ML, et al. Linking beaver dam affected flow dynamics to upstream passage of Arctic grayling. Ecol Evol. 2018;8(24):12905-12917doi: 10.1002/ece3.4728.
Cutting, K. A., Ferguson, J. M., Anderson, M. L., Cook, K., Davis, S. C., & Levine, R. (2018). Linking beaver dam affected flow dynamics to upstream passage of Arctic grayling. Ecology and evolution, 8(24), 12905-12917. https://doi.org/10.1002/ece3.4728
Cutting, Kyle A, et al. "Linking beaver dam affected flow dynamics to upstream passage of Arctic grayling." Ecology and evolution vol. 8,24 (2018): 12905-12917. doi: https://doi.org/10.1002/ece3.4728
Cutting KA, Ferguson JM, Anderson ML, Cook K, Davis SC, Levine R. Linking beaver dam affected flow dynamics to upstream passage of Arctic grayling. Ecol Evol. 2018 Dec 04;8(24):12905-12917. doi: 10.1002/ece3.4728. eCollection 2018 Dec. PMID: 30619592; PMCID: PMC6308880.
Copy Download .nbib Format: NLM
Electrical tuning of optically active interlayer excitons in bilayer MoS.

Nature nanotechnology

Peimyoo N, Deilmann T, Withers F, Escolar J, Nutting D, Taniguchi T, Watanabe K, Taghizadeh A, Craciun MF, Thygesen KS, Russo S.
PMID: 34083771
Nat Nanotechnol. 2021 Aug;16(8):888-893. doi: 10.1038/s41565-021-00916-1. Epub 2021 Jun 03.

Interlayer (IL) excitons, comprising electrons and holes residing in different layers of van der Waals bonded two-dimensional semiconductors, have opened new opportunities for room-temperature excitonic devices. So far, two-dimensional IL excitons have been realized in heterobilayers with type-II band...

Cite
Peimyoo N, Deilmann T, Withers F, et al. Electrical tuning of optically active interlayer excitons in bilayer MoS. Nat Nanotechnol. 2021;16(8):888-893doi: 10.1038/s41565-021-00916-1.
Peimyoo, N., Deilmann, T., Withers, F., Escolar, J., Nutting, D., Taniguchi, T., Watanabe, K., Taghizadeh, A., Craciun, M. F., Thygesen, K. S., & Russo, S. (2021). Electrical tuning of optically active interlayer excitons in bilayer MoS. Nature nanotechnology, 16(8), 888-893. https://doi.org/10.1038/s41565-021-00916-1
Peimyoo, Namphung, et al. "Electrical tuning of optically active interlayer excitons in bilayer MoS." Nature nanotechnology vol. 16,8 (2021): 888-893. doi: https://doi.org/10.1038/s41565-021-00916-1
Peimyoo N, Deilmann T, Withers F, Escolar J, Nutting D, Taniguchi T, Watanabe K, Taghizadeh A, Craciun MF, Thygesen KS, Russo S. Electrical tuning of optically active interlayer excitons in bilayer MoS. Nat Nanotechnol. 2021 Aug;16(8):888-893. doi: 10.1038/s41565-021-00916-1. Epub 2021 Jun 03. PMID: 34083771.
Copy Download .nbib Format: NLM
Inter-Observer Variation in Delineating the Pharyngeal Constrictor Muscle as Organ at Risk in Radiotherapy for Head and Neck Cancer.

Frontiers in oncology

Petkar I, McQuaid D, Dunlop A, Tyler J, Hall E, Nutting C.
PMID: 33768005
Front Oncol. 2021 Mar 09;11:644767. doi: 10.3389/fonc.2021.644767. eCollection 2021.

BACKGROUND AND PURPOSE: To evaluate the inter-observer variation (IOV) in pharyngeal constrictor muscle (PCM) contouring, and resultant impact on dosimetry and estimated toxicity, as part of the pre-trial radiotherapy trial quality assurance (RTQA) within DARS, a multicenter phase III...

Cite
Petkar I, McQuaid D, Dunlop A, et al. Inter-Observer Variation in Delineating the Pharyngeal Constrictor Muscle as Organ at Risk in Radiotherapy for Head and Neck Cancer. Front Oncol. 2021;11:644767doi: 10.3389/fonc.2021.644767.
Petkar, I., McQuaid, D., Dunlop, A., Tyler, J., Hall, E., & Nutting, C. (2021). Inter-Observer Variation in Delineating the Pharyngeal Constrictor Muscle as Organ at Risk in Radiotherapy for Head and Neck Cancer. Frontiers in oncology, 11644767. https://doi.org/10.3389/fonc.2021.644767
Petkar, Imran, et al. "Inter-Observer Variation in Delineating the Pharyngeal Constrictor Muscle as Organ at Risk in Radiotherapy for Head and Neck Cancer." Frontiers in oncology vol. 11 (2021): 644767. doi: https://doi.org/10.3389/fonc.2021.644767
Petkar I, McQuaid D, Dunlop A, Tyler J, Hall E, Nutting C. Inter-Observer Variation in Delineating the Pharyngeal Constrictor Muscle as Organ at Risk in Radiotherapy for Head and Neck Cancer. Front Oncol. 2021 Mar 09;11:644767. doi: 10.3389/fonc.2021.644767. eCollection 2021. PMID: 33768005; PMCID: PMC7985335.
Copy Download .nbib Format: NLM
Origin Storytelling in Faculty Well-being: A Pilot Study.

PRiMER (Leawood, Kan.)

Nutting R, Nilsen K, Walling A, Level E.
PMID: 34286218
PRiMER. 2021 May 24;5:15. doi: 10.22454/PRiMER.2021.833623. eCollection 2021.

BACKGROUND AND OBJECTIVES: In 2020, approximately 47% of family physicians reported burnout. For physicians, professional burnout is implicated in damage to relationships, increased rates of alcohol and/or substance abuse, depression, and suicide. Professional isolation can be a major contributor...

Cite
Nutting R, Nilsen K, Walling A, et al. Origin Storytelling in Faculty Well-being: A Pilot Study. PRiMER. 2021;5:15doi: 10.22454/PRiMER.2021.833623.
Nutting, R., Nilsen, K., Walling, A., & Level, E. (2021). Origin Storytelling in Faculty Well-being: A Pilot Study. PRiMER (Leawood, Kan.), 515. https://doi.org/10.22454/PRiMER.2021.833623
Nutting, Ruth, et al. "Origin Storytelling in Faculty Well-being: A Pilot Study." PRiMER (Leawood, Kan.) vol. 5 (2021): 15. doi: https://doi.org/10.22454/PRiMER.2021.833623
Nutting R, Nilsen K, Walling A, Level E. Origin Storytelling in Faculty Well-being: A Pilot Study. PRiMER. 2021 May 24;5:15. doi: 10.22454/PRiMER.2021.833623. eCollection 2021. PMID: 34286218; PMCID: PMC8284488.
Copy Download .nbib Format: NLM
Rehabilitation 2030: a collective call that requires individual action.

Brazilian journal of physical therapy

Hartman J, Duttine A.
PMID: 34274241
Braz J Phys Ther. 2021 Jun 30; doi: 10.1016/j.bjpt.2021.06.004. Epub 2021 Jun 30.

No abstract available.

Cite
Hartman J, Duttine A. Rehabilitation 2030: a collective call that requires individual action. Braz J Phys Ther. 2021;doi: 10.1016/j.bjpt.2021.06.004.
Hartman, J., & Duttine, A. (2021). Rehabilitation 2030: a collective call that requires individual action. Brazilian journal of physical therapy, . https://doi.org/10.1016/j.bjpt.2021.06.004
Hartman, Jeff, and Duttine, Antony. "Rehabilitation 2030: a collective call that requires individual action." Brazilian journal of physical therapy vol. (2021). doi: https://doi.org/10.1016/j.bjpt.2021.06.004
Hartman J, Duttine A. Rehabilitation 2030: a collective call that requires individual action. Braz J Phys Ther. 2021 Jun 30; doi: 10.1016/j.bjpt.2021.06.004. Epub 2021 Jun 30. PMID: 34274241.
Copy Download .nbib Format: NLM
A guide to cranial nerve testing for musculoskeletal clinicians.

The Journal of manual & manipulative therapy

Taylor A, Mourad F, Kerry R, Hutting N.
PMID: 34182898
J Man Manip Ther. 2021 Dec;29(6):376-389. doi: 10.1080/10669817.2021.1937813. Epub 2021 Jun 29.

BACKGROUND: Neurological examination in musculoskeletal practice is a key element of safe and appropriate orthopedic clinical practice. With physiotherapists currently positioning themselves as advanced first line practitioners, it is essential that those who treat patients who present with neck/head/orofacial...

Cite
Taylor A, Mourad F, Kerry R, et al. A guide to cranial nerve testing for musculoskeletal clinicians. J Man Manip Ther. 2021;29(6):376-389doi: 10.1080/10669817.2021.1937813.
Taylor, A., Mourad, F., Kerry, R., & Hutting, N. (2021). A guide to cranial nerve testing for musculoskeletal clinicians. The Journal of manual & manipulative therapy, 29(6), 376-389. https://doi.org/10.1080/10669817.2021.1937813
Taylor, Alan, et al. "A guide to cranial nerve testing for musculoskeletal clinicians." The Journal of manual & manipulative therapy vol. 29,6 (2021): 376-389. doi: https://doi.org/10.1080/10669817.2021.1937813
Taylor A, Mourad F, Kerry R, Hutting N. A guide to cranial nerve testing for musculoskeletal clinicians. J Man Manip Ther. 2021 Dec;29(6):376-389. doi: 10.1080/10669817.2021.1937813. Epub 2021 Jun 29. PMID: 34182898.
Copy Download .nbib Format: NLM
Myositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype.

The European respiratory journal

Graham J, Bauer Ventura I, Newton CA, Lee C, Boctor N, Pugashetti JV, Cutting C, Joerns E, Sandhu H, Chung JH, Garcia CK, Kadoch M, Noth I, Adegunsoye A, Strek ME, Oldham JM.
PMID: 32675203
Eur Respir J. 2020 Jul 16; doi: 10.1183/13993003.01205-2020. Epub 2020 Jul 16.

Interstitial pneumonia with autoimmune features (IPAF) characterises individuals with interstitial lung disease (ILD) and features of connective tissue disease (CTD) who fail to satisfy CTD criteria. Inclusion of myositis-specific antibodies (MSAs) in the IPAF criteria has generated controversy, as...

Cite
Graham J, Bauer Ventura I, Newton CA, et al. Myositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype. Eur Respir J. 2020;doi: 10.1183/13993003.01205-2020.
Graham, J., Bauer Ventura, I., Newton, C. A., Lee, C., Boctor, N., Pugashetti, J. V., Cutting, C., Joerns, E., Sandhu, H., Chung, J. H., Garcia, C. K., Kadoch, M., Noth, I., Adegunsoye, A., Strek, M. E., & Oldham, J. M. (2020). Myositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype. The European respiratory journal, . https://doi.org/10.1183/13993003.01205-2020
Graham, Julia, et al. "Myositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype." The European respiratory journal vol. (2020). doi: https://doi.org/10.1183/13993003.01205-2020
Graham J, Bauer Ventura I, Newton CA, Lee C, Boctor N, Pugashetti JV, Cutting C, Joerns E, Sandhu H, Chung JH, Garcia CK, Kadoch M, Noth I, Adegunsoye A, Strek ME, Oldham JM. Myositis-specific Antibodies Identify A Distinct Interstitial Pneumonia with Autoimmune Features Phenotype. Eur Respir J. 2020 Jul 16; doi: 10.1183/13993003.01205-2020. Epub 2020 Jul 16. PMID: 32675203; PMCID: PMC7943372.
Copy Download .nbib Format: NLM
Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma.

Oncogenesis

Weidner P, Söhn M, Schroeder T, Helm L, Hauber V, Gutting T, Betge J, Röcken C, Rohrbacher FN, Pattabiraman VR, Bode JW, Seger R, Saar D, Nunes-Alves A, Wade RC, Ebert MPA, Burgermeister E.
PMID: 32522977
Oncogenesis. 2020 Jun 10;9(6):59. doi: 10.1038/s41389-020-0238-8.

Peroxisome proliferator-activated receptor-gamma (PPARγ) is a transcription factor drugable by agonists approved for treatment of type 2 diabetes, but also inhibits carcinogenesis and cell proliferation in vivo. Activating mutations in the Kirsten rat sarcoma viral oncogene homologue (KRAS) gene...

Cite
Weidner P, Söhn M, Schroeder T, et al. Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma. Oncogenesis. 2020;9(6):59doi: 10.1038/s41389-020-0238-8.
Weidner, P., Söhn, M., Schroeder, T., Helm, L., Hauber, V., Gutting, T., Betge, J., Röcken, C., Rohrbacher, F. N., Pattabiraman, V. R., Bode, J. W., Seger, R., Saar, D., Nunes-Alves, A., Wade, R. C., Ebert, M. P. A., & Burgermeister, E. (2020). Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma. Oncogenesis, 9(6), 59. https://doi.org/10.1038/s41389-020-0238-8
Weidner, Philip, et al. "Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma." Oncogenesis vol. 9,6 (2020): 59. doi: https://doi.org/10.1038/s41389-020-0238-8
Weidner P, Söhn M, Schroeder T, Helm L, Hauber V, Gutting T, Betge J, Röcken C, Rohrbacher FN, Pattabiraman VR, Bode JW, Seger R, Saar D, Nunes-Alves A, Wade RC, Ebert MPA, Burgermeister E. Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma. Oncogenesis. 2020 Jun 10;9(6):59. doi: 10.1038/s41389-020-0238-8. PMID: 32522977; PMCID: PMC7286916.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 125 entries